Literature DB >> 2712545

Influence of two quinolones, ofloxacin and pefloxacin, on human myelopoiesis in vitro.

F Pallavicini1, A Antinori, G Federico, M Fantoni, P Nervo.   

Abstract

The influence of ofloxacin and pefloxacin on human myelopoiesis in vitro was investigated. Drug concentrations varied from 0.5 to 50 micrograms/ml, and the effect on granulomonocyte precursors was evaluated on cell cultures in agar. Our results indicate that ofloxacin and pefloxacin do not induce inhibition of myelopoiesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2712545      PMCID: PMC171436          DOI: 10.1128/AAC.33.1.122

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Aryl-fluoroquinolone derivatives A-56619 (difloxacin) and A-56620 inhibit mitogen-induced human mononuclear cell proliferation.

Authors:  S V Gollapudi; B Vayuvegula; S Gupta; M Fok; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

2.  Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis.

Authors:  C De Simone; L Baldinelli; M Ferrazzi; S De Santis; L Pugnaloni; F Sorice
Journal:  J Antimicrob Chemother       Date:  1986-06       Impact factor: 5.790

3.  Influence of ofloxacin and pefloxacin on human lymphocyte immunoglobulin secretion and on polymorphonuclear leucocyte superoxide anion production.

Authors:  M Fantoni; E Tamburrini; F Pallavicini; A Antinori; P Nervo
Journal:  J Antimicrob Chemother       Date:  1988-08       Impact factor: 5.790

4.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

5.  Human bone marrow colony growth in agar-gel.

Authors:  B L Pike; W A Robinson
Journal:  J Cell Physiol       Date:  1970-08       Impact factor: 6.384

6.  Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts.

Authors:  P Hussy; G Maass; B Tümmler; F Grosse; U Schomburg
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

7.  Effects of ciprofloxacin on the humoral and cellular immune responses in Balb/c-mice.

Authors:  W Roszkowski; H L Ko; K Roszkowski; P Ciborowski; J Jeljaszewicz; G Pulverer
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-09

8.  Effect of ciprofloxacin on phagocytosis.

Authors:  A Forsgren; P I Bergkvist
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

9.  Quinolones affect thymidine incorporation into the DNA of human lymphocytes.

Authors:  A Forsgren; A K Bergh; M Brandt; G Hansson
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

10.  Effect of ciprofloxacin on mitogen-stimulated lymphocyte proliferation.

Authors:  S V Gollapudi; R H Prabhala; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

View more
  4 in total

Review 1.  Immunological aspects of new quinolones.

Authors:  I Shalit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

2.  Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.

Authors:  K Hoshino; K Sato; T Une; Y Osada
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 3.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

4.  Modification of immune response in mice by ciprofloxacin.

Authors:  M Jimenez-Valera; A Sampedro; E Moreno; A Ruiz-Bravo
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.